Coping Skills Training for Anxiety and Stress
(Blueprint 2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a mobile app called Blueprint, designed to help people manage anxiety and stress after serious health issues like heart failure or severe COVID pneumonia. The app teaches coping skills to improve mental health and quality of life, particularly for those recently in intensive care. Participants will use either the Blueprint app or an educational app for comparison. Individuals who were in intensive care with serious heart or lung problems and feel anxious or stressed might be a good fit for this trial. As an unphased trial, this study provides a unique opportunity to explore innovative ways to enhance mental well-being after intensive care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a mobile app for coping skills, so it's likely you can continue your current medications, but you should confirm with the trial coordinators.
What prior data suggests that the Blueprint mobile app is safe for improving mental health symptoms?
Research has shown that the Blueprint mobile app is generally safe for users. In a previous study, participants using Blueprint experienced less depression and improved quality of life compared to those using a placebo app. Importantly, the study reported no serious side effects, suggesting the app is well-tolerated for its intended use.
Developed and refined over many years, the Blueprint app helps patients manage stress and anxiety after ICU stays. It is easy to use and aims to teach coping skills through a month-long program. While further research is needed to confirm these findings, early results are promising for its safety and effectiveness.12345Why are researchers excited about this trial?
Researchers are excited about the Blueprint adaptive coping skills intervention because it offers a personalized approach through a mobile app specifically targeting anxiety and stress in patients with cardiorespiratory conditions. Unlike traditional methods that might involve general therapy or medication, Blueprint provides tailored content delivered weekly, ensuring it adapts to individual needs. This innovative delivery method not only makes it more accessible but also includes safety monitoring through in-app surveys, enhancing patient engagement and potentially leading to better outcomes.
What evidence suggests that the Blueprint mobile app is effective for anxiety and stress?
Research has shown that the Blueprint app, which teaches coping skills, delivers promising results. In this trial, participants in one arm will use the Blueprint app, which earlier studies have shown helps users feel less depressed and improves their quality of life compared to those using a placebo app. The app is user-friendly and offers various content types, such as audio, video, and text, over four weeks to aid in managing mental health. This approach aims to make mental health care more accessible, especially for those who cannot easily access traditional services. Overall, early findings suggest Blueprint could be a helpful tool for people recovering from ICU care and dealing with anxiety or stress.45678
Who Is on the Research Team?
Christopher Cox
Principal Investigator
Professor of Medicine
Are You a Good Fit for This Trial?
This trial is for survivors of cardiorespiratory failure who have been in the ICU and are experiencing psychological distress such as depression, anxiety, or PTSD. It's particularly focused on including patients from racially and ethnically minoritized groups.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the Blueprint mobile app or an Education Program mobile app for 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Blueprint
- Education program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
University of Colorado, Denver
Collaborator
Oregon Health and Science University
Collaborator
University of California, Los Angeles
Collaborator